INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against BioAge Labs, Inc. (NASDAQ: BIOA); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge” or the “Company”) common stock pursuant and/or traceable to BioAge’s registration statement for the initial public offering held on or about September 26, 2024 (the “IPO”), charging the Company and certain of its current senior executives and directors with violations of the federal securities laws (collectively, “Defendants”). Bio ...